Dyno Patents

Patent portfolio assigned to Dyno (verified via public assignee records). Dyno Therapeutics - AI-driven AAV gene therapy capsid engineering. Partners/customers named on Dyno's own news page (Roche strategic collaboration up to ~$1.8B incl. $50M upfront; Astellas, Sarepta as therapeutic-developer partners; NVIDIA as tech partner). has_patents=true: Google Patents lists patents assigned to 'Dyno Therapeutics Inc' (e.g. WO2024191778A1 capsid polypeptides, AU2023253718A1 capsid variants); total count not reliably available. Competitors empty: no primary fetched source naming direct competitors.